On the basis of spectroscopic and chemical evidence, the structures of WS-9659A and B isolated as inhibitors of testosterone 5a-reductase from a Streptomyces have been established as 1 and 2, respectively. The reductase inhibitory activities of the derivatives 5 and 6, and degradation products 3 and 8 were considerably less active and substantially inactive, respectively.
WS-9659
A On the basis of spectroscopic and chemical evidence, the structures of WS-9659A and B isolated as inhibitors of testosterone 5a-reductase from a Streptomyces have been established as 1 and 2, respectively. The reductase inhibitory activities of the derivatives 5 and 6, and degradation products 3 and 8 were considerably less active and substantially inactive, respectively.
Inhibition of the enzyme testosterone 5a-reductase represents a new pharmacological approach toward the treatment of benign prostate hyperplasia which appears to be mediated by 5a-dihydrotestosteronei:>. As part of a program aimed at the discovery of inhibitors of this enzyme, we isolated WS-9659 A (1) as a potent and specific inhibitor, together with WS-9659 B (2) as a minor product, from Streptomyces sp. No. 96592). Herein we report the structural elucidation of these newnatural products. The biological activities of the derivatives and degradation products obtained from 1 during the elucidation are also described. The major species WS-9659 A (1) On treatment with 1 n NaOH(room temperature, 30 minutes), 1 was easily decomposed to two products 3 and 4\ The former was identified to be 1-hydroxyphenazine by inspection of its physical data (see Experimental section) and finally by comparison with an authentic sample. The other product was found to be a tetra-substituted, a,/3-unsaturated aldehyde (IR (CHCl3) cm~1 1660; 8C 191.0 (s), T In the alkaline treatment, 1 suffered an air oxidation, yielding 3 and 4. In the literature3), a similar oxidation had also been reported on pyocyanine (9), which gave 1-hydroxyphenazine and formic acid upon treatment with alkaline. ). These data were identical with those of /3-cyclolavandulal (4)4). The aldehyde was thus determined to be 4. The problem remaining for the full structure of 1 is to link 1-hydroxyphenazine (3) and /3-cyclolavandulal (4). This was accomplished by nuclear Overhauser effect (NOE) studies on the derivatives of 1 as follows. Acetylation of 1 with Ac2Oin pyridine gave diacetates 5 and 6, together with /3-cyclolavandulal (4), 1-acetoxyphenazine (7) and 5,10-dihydro-1-hydroxyphenazine diacetate (8) (4 and 8 were probably formed by hydrolysis of 6 during the workup). In the XH NMRspectrum (CDC13) of 5, three aromatic protons adjacent to each other were observed at d 6.81, 7.20 and 6.85 (Table 1) . Irradiation of the methylene protons (d 4.49) assignable to l'-H (2H) enhanced the intensities of the signal at d 6.81 (which was thereby assigned to 4-H; hence d 7.20 to 3-H and d 6.85 to 2-H), indicating that the^-cyclolavandulal substituent is linked to N-5. The aromatic proton at d 6.91, which is one of the four serially connected protons (the others: 5 7.18 (7-H), 7.04 (8-H) and 7.34 (9-H)), was also increased in intensity on irradiation of l'-H, being assigned to 6-H. A NOEexperiment was also carried out on compound 6 and the result showed NOE's between l'-H (<5 6.24, s) and 4-H (<5 6.85, d, /=8.2 Hz), and l'-H and 6-H (3 6.96, d, /=8.2 Hz), leading to the same conclusion as described above. In this latter experiment, a NOEwas also observed between l'-H and 3/-CH3 (<5 2.O6, s), revealing that the l'^'-double bond in 6 is E. The structure of WS-9659 A was thus assigned to be 1. The minor species WS-9659 B (2) was isolated as deep blue prisms (mp 152~153°C). The molecular formula, C22H23N2OC1 (elemental analysis and FAB-MS), showed that 2 is a chloro derivative of 1. The XHNMRspectrum (CDC18) of 2 showed a signal pattern similar to that of 1 (Table 1 ). An exception is that the proton signal corresponding to that at d 6.55 (probably 2-H) in 1 was not observed in 2. A NOEstudy on 2 showed that irradiation of l'-H (d 5.12) enhanced the intensities of the protons at d 5.89 (4-H) and 7.58 (6-H) as in the case of 5. These facts suggested that the chlorine is located at the 2-position in 2. The structure of WS-9659 B was thus presumed to be 2. These natural products, WS-9659 A and B may exist as a mixture of tautomers a and b as depicted in Fig. 1 . Each of the compounds derived from 1 was evaluated in vitro for inhibition of testosterone 5ar-reductase and the results were given in comparison with those of WS-9659 A (1), B (2) and pyocyanine (9) in Table 2 . All the derivatives and degradation products were found to be considerahiv less notent. nr snhstantiaiiv inactive.
It is notable, however, that pyocyanine showed an activity of the same order as 1. Experimenta l IR spectra were recorded on a Jasco A-102 spectrophotometer. XHand 13C NMRspectra were measured on a Bruker AM400WB spectrometer. The chemical shifts are given in ppm (d) relative to internal TMS.UVspectra were measured on a Hitachi 220A spectrophotometer. Electron impact (El)-and FAB-MS were recorded using a VGZAB-SEmass spectrometer. MP's were measured with a Yanagimoto microscope hot-stage apparatus and are uncorrected. Preparative TLC(PTLC) was performed on pre-coated Silica gel 60 F254 plates (E. Merck). Biological assay was carried out according to the method described in the preceding paper of this series.
WS-9659 A (1) Treatment of 1 with 1 n NaOH To a solution of 1 (50mg) in MeOH(2ml) was added 1 n NaOH(1 ml) and the mixture was stirred for 30 minutes at room temperature. After acidification to pH 1 with 1 n HC1, the mixture was extracted with EtOAc, dried over MgSO4 and evaporated in vacuo to give an oily residue, which was purified by PTLC developing with CHC13 to give 3 (15 mg) and 4 (7.3 mg). Acetylation of 1 To a solution of 1 (50mg) in pyridine (1 ml) was added Ac2O (100 /4) and the mixture was stirred for 60 hours at roomtemperature. After evaporation of the mixture in vacuo, the residue was purified by PTLC developing with hexane-CHC13 (1 :1) to give 4 (7.4mg) and 8 (8.3 mg). PTLC was repeated on the other fractions and developed with hexane -CHC13 -EtOAc (4 : 4 : 1) to give 7 (6.9 mg). The other fractions were further developed on TLC with CH2C12to give 5 (9.7 mg) and 6 (3.9 mg).
